Medical research plays an incredibly important role in scientific discovery and Victoria’s economy. The Victorian Government is committed to supporting all forms of medical research and driving innovation to enable home grown inventions to be manufactured right here in Victoria.
Victoria’s health and medical research sector
Victoria is the premier location for medical research and clinical trials in Australia and recognised globally as a health and medical research centre of excellence.
Victoria is home to 18 world-class medical research institutes which, together, employ over 6,000 people. The state’s wider medical research sector supports more than 30,000 jobs across institutes, universities and industry.
The Victorian research community and industry drives high-quality health and medical research across the state, including critical investigator-led and collaborative group research.
Translation of this research into evidence-based medical interventions means that Victorians can receive the most innovative care and clinical treatments available.
The Victorian Government has committed $1.3 billion to medical research since 2014.
That investment has helped Victoria to emerge as a world leader in cutting-edge health and medical research – driving growth in the sector, creating jobs and supporting incredible breakthroughs in treatment and care.
More clinical trials and medical research projects conducted here in Victoria means greater access to life-improving treatments for Victorians – and more jobs and economic growth across the state.
Victorian Budget 2021-22
The Victorian Budget 2021-22 invests $68.8 million for health‑related research.
$50 million to establish commercial-scale mRNA vaccine manufacturing capability in Victoria. Developing mRNA capability in Victoria will provide vaccine security, support local manufacturing and create a more robust defence against future pandemics.
An additional $14 million to continue GenV, the Murdoch Children’s Research Institute’s ground-breaking research study tracking a generation of Victorians to paint a complete picture of their health and wellbeing.
Led by Monash University and Cochrane Australia, the Australian Living Evidence Consortium has delivered the world’s only Living Guidelines for COVID‑19. A new $4 million investment will support the second phase of the project, which will bring together the best treatments from around the world for people living with chronic diseases such as diabetes, heart disease, kidney disease, stroke and arthritis.
A new Aboriginal Health and Medical Research Accord will receive $750,000 to support health researchers from Aboriginal communities to lead and improve the way research involving Aboriginal people and communities is undertaken.
Enquiries can be submitted via our contact form.
Page last updated: 22 October 2021